Wednesday, March 9, 2016
1:15 – 2:30pm
N-of-One Trials: Is This the Future of Oncology Drug Development?
- Brian Leyland-Jones, MD, PhD, Vice President of the Avera Center for Precision Oncology and the Department of Molecular and Experimental Medicine, Avera Cancer Institute, Consulting Professor, Stanford University School of Medicine
- Michael Doherty, Head, Strategic Innovation, Roche and Genentech, Executive Adviser, Foundation Medicine Inc.
- Sean Khozin, MD, MPH, Senior Medical Officer, Thoracic Oncologist, FDA
- Nicholas J. Schork, PhD, Professor and Director, Human Biology, J. Craig Venter Institute
- John J. Sninsky, PhD, Chief Scientific Officer, CareDX